Codeine 30 30 mg

Codeine phosphate, the active ingredient in CODEINE 30, is an opioid analgesic presented as a 30 mg tablet for oral use. It is used to relieve mild to moderate pain and suppress coughs in adults and children over 12 years of age. GNH USA supplies CODEINE 30 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

GNH USA is a trusted global supplier of high-quality pharmaceuticals, ensuring that CODEINE 30 meets international standards for safety and efficacy.

CODEINE 30 is an opioid analgesic used to manage pain and suppress coughs. It acts on the central nervous system to provide relief.

- Mild to moderate pain: Provides relief from pain that is not adequately managed by non-opioid analgesics. - Cough suppression: Helps control non-productive coughs in adults and children over 12 years of age. - Diarrhea relief: Used for symptomatic relief of diarrhea in adults when other treatments are insufficient.

CODEINE 30 may cause various side effects, ranging from common to serious.

Common Side Effects: - Nausea and vomiting. - Dizziness and drowsiness. - Constipation. - Dry mouth. - Headache. - Sweating.

Serious or Rare Side Effects: - Respiratory depression. - Severe allergic reactions. - Confusion and hallucinations. - Dependence and addiction. - Seizures. - Liver toxicity.

CODEINE 30 should be used with caution and under medical supervision.

- Pregnancy: Use only if clearly needed and under medical supervision. - Breastfeeding: Avoid or use with caution. - Children: Not recommended for children under 12 years of age. - Elderly: Use with caution due to increased sensitivity. - Renal impairment: Adjust dosage as needed. - Hepatic impairment: Adjust dosage as needed. - Store below 25°C: Keep in the original pack, protect from moisture and light.

CODEINE 30 can interact with other medications, potentially altering its effects or increasing the risk of side effects.

Major Interactions (Avoid): - Alcohol: Increases the risk of respiratory depression and sedation. - Other opioids: Enhances the risk of overdose and respiratory depression. - MAO inhibitors: Can cause severe reactions, including serotonin syndrome.

Moderate Interactions (Monitor Closely): - Antidepressants: May increase the risk of sedation and respiratory depression. - Antihistamines: Can enhance sedative effects. - Sedatives: Increases the risk of excessive drowsiness and respiratory depression.